Birdwatch Archive

Birdwatch Note

2023-04-24 15:57:54 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING

Emergency use authorizations were used to bring vaccines to clinical use at a time when rapid progress in tackling the pandemic was vital to save lives. They do not exempt the manufacturer from providing clinical safety data, not render them immune to prosecution. https://www.fda.gov/vaccines-blood-biologics/vaccines/emergency-use-authorization-vaccines-explained

Written by 90416E1B6428DAC3DEE3425B5DE230C9667981195596BEF73A633C6C646107CD
Participant Details

Original Tweet

Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1650378317504159744

Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.

All Information

  • ID - 1650529506560442368
  • noteId - 1650529506560442368
  • participantId -
  • noteAuthorParticipantId - 90416E1B6428DAC3DEE3425B5DE230C9667981195596BEF73A633C6C646107CD Participant Details
  • createdAtMillis - 1682351874377
  • tweetId - 1650378317504159744
  • classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
  • believable -
  • harmful -
  • validationDifficulty -
  • misleadingOther - 0
  • misleadingFactualError - 0
  • misleadingManipulatedMedia - 0
  • misleadingOutdatedInformation - 0
  • misleadingMissingImportantContext - 1
  • misleadingUnverifiedClaimAsFact - 1
  • misleadingSatire - 0
  • notMisleadingOther - 0
  • notMisleadingFactuallyCorrect - 0
  • notMisleadingOutdatedButNotWhenWritten - 0
  • notMisleadingClearlySatire - 0
  • notMisleadingPersonalOpinion - 0
  • trustworthySources - 1
  • summary
    • Emergency use authorizations were used to bring vaccines to clinical use at a time when rapid progress in tackling the pandemic was vital to save lives. They do not exempt the manufacturer from providing clinical safety data, not render them immune to prosecution. https://www.fda.gov/vaccines-blood-biologics/vaccines/emergency-use-authorization-vaccines-explained

Note Status History

createdAt timestampMillisOfFirstNonNMRStatus firstNonNMRStatus timestampMillisOfCurrentStatus currentStatus timestampMillisOfLatestNonNMRStatus mostRecentNonNMRStatus participantId
2023-04-24 15:57:54 UTC
(1682351874377)
1969-12-31 23:59:59 UTC
(-1)
2023-05-06 02:42:24 UTC
(1683340944665)
NEEDS_MORE_RATINGS 1969-12-31 23:59:59 UTC
(-1)

Note Ratings

rated at rated by
2023-05-04 09:13:04 -0500 Rating Details
2023-04-24 16:03:02 -0500 Rating Details
2023-04-24 16:10:14 -0500 Rating Details
2023-04-24 13:28:30 -0500 Rating Details
2023-04-24 11:06:00 -0500 Rating Details
2023-04-24 14:38:12 -0500 Rating Details
2023-04-24 15:28:29 -0500 Rating Details
2023-04-24 15:29:45 -0500 Rating Details
2023-04-24 15:10:18 -0500 Rating Details
2023-04-24 15:13:28 -0500 Rating Details
2023-04-24 16:44:32 -0500 Rating Details
2023-04-24 14:04:32 -0500 Rating Details
2023-04-24 15:17:21 -0500 Rating Details
2023-04-24 15:11:59 -0500 Rating Details
2023-04-24 14:00:12 -0500 Rating Details
2023-04-24 13:09:36 -0500 Rating Details
2023-04-24 15:44:56 -0500 Rating Details
2023-04-24 14:52:28 -0500 Rating Details
2023-04-24 14:50:04 -0500 Rating Details
2023-04-24 14:21:20 -0500 Rating Details
2023-04-24 15:50:09 -0500 Rating Details
2023-04-24 14:39:34 -0500 Rating Details
2023-04-24 16:03:26 -0500 Rating Details
2023-04-24 14:07:36 -0500 Rating Details
2023-04-24 12:56:21 -0500 Rating Details
2023-04-24 15:28:53 -0500 Rating Details
2023-04-24 13:53:29 -0500 Rating Details
2023-04-24 13:36:53 -0500 Rating Details
2023-04-24 14:26:22 -0500 Rating Details
2023-04-24 15:05:34 -0500 Rating Details
2023-04-25 11:51:39 -0500 Rating Details
2023-04-24 13:48:38 -0500 Rating Details
2023-04-24 13:44:09 -0500 Rating Details
2023-04-24 15:09:14 -0500 Rating Details
2023-04-24 13:21:30 -0500 Rating Details
2023-04-24 15:26:44 -0500 Rating Details
2023-04-24 15:35:35 -0500 Rating Details
2023-04-24 15:57:56 -0500 Rating Details
2023-04-24 15:31:23 -0500 Rating Details
2023-04-24 13:54:19 -0500 Rating Details
2023-04-24 15:43:08 -0500 Rating Details
2023-04-24 16:26:01 -0500 Rating Details
2023-04-24 14:12:49 -0500 Rating Details
2023-04-24 16:14:02 -0500 Rating Details
2023-04-24 14:23:16 -0500 Rating Details
2023-04-24 15:05:56 -0500 Rating Details
2023-04-24 16:50:16 -0500 Rating Details
2023-04-24 14:00:23 -0500 Rating Details
2023-04-24 13:47:25 -0500 Rating Details
2023-04-24 16:00:53 -0500 Rating Details
2023-04-24 13:34:47 -0500 Rating Details
2023-04-24 15:42:48 -0500 Rating Details
2023-04-24 14:15:24 -0500 Rating Details
2023-04-24 13:48:58 -0500 Rating Details
2023-04-24 15:54:16 -0500 Rating Details
2023-04-24 16:08:20 -0500 Rating Details
2023-04-24 16:04:09 -0500 Rating Details
2023-04-24 15:45:32 -0500 Rating Details
2023-04-24 14:10:10 -0500 Rating Details
2023-04-24 14:07:10 -0500 Rating Details
2023-04-24 16:24:59 -0500 Rating Details
2023-04-24 15:59:29 -0500 Rating Details
2023-04-24 14:20:45 -0500 Rating Details
2023-04-24 15:01:26 -0500 Rating Details
2023-04-24 13:42:05 -0500 Rating Details
2023-04-24 15:41:09 -0500 Rating Details
2023-04-24 15:35:33 -0500 Rating Details
2023-04-24 13:49:07 -0500 Rating Details
2023-04-24 16:03:02 -0500 Rating Details
2023-04-24 16:10:14 -0500 Rating Details
2023-04-24 13:28:30 -0500 Rating Details
2023-04-24 11:06:00 -0500 Rating Details
2023-04-24 14:38:12 -0500 Rating Details
2023-04-24 15:28:29 -0500 Rating Details
2023-04-24 15:29:45 -0500 Rating Details
2023-04-24 15:10:18 -0500 Rating Details
2023-04-24 15:13:28 -0500 Rating Details
2023-04-24 16:44:32 -0500 Rating Details
2023-04-24 14:04:32 -0500 Rating Details
2023-04-24 15:17:21 -0500 Rating Details
2023-04-24 15:11:59 -0500 Rating Details
2023-04-24 14:00:12 -0500 Rating Details
2023-04-24 13:09:36 -0500 Rating Details
2023-04-24 15:44:56 -0500 Rating Details
2023-04-24 14:52:28 -0500 Rating Details
2023-04-24 14:50:04 -0500 Rating Details
2023-04-24 14:21:20 -0500 Rating Details
2023-04-24 15:50:09 -0500 Rating Details
2023-04-24 14:39:34 -0500 Rating Details
2023-05-04 09:13:04 -0500 Rating Details
2023-04-24 16:03:26 -0500 Rating Details
2023-04-24 14:07:36 -0500 Rating Details
2023-04-24 12:56:21 -0500 Rating Details
2023-04-24 15:28:53 -0500 Rating Details
2023-04-24 13:53:29 -0500 Rating Details
2023-04-24 13:36:53 -0500 Rating Details
2023-04-24 14:26:22 -0500 Rating Details
2023-04-24 15:05:34 -0500 Rating Details
2023-04-25 11:51:39 -0500 Rating Details
2023-04-24 13:48:38 -0500 Rating Details
2023-04-24 13:44:09 -0500 Rating Details
2023-04-24 15:09:14 -0500 Rating Details
2023-04-24 13:21:30 -0500 Rating Details
2023-04-24 15:26:44 -0500 Rating Details
2023-04-24 15:35:35 -0500 Rating Details
2023-04-24 15:57:56 -0500 Rating Details
2023-04-24 15:31:23 -0500 Rating Details
2023-04-24 13:54:19 -0500 Rating Details
2023-04-24 15:43:08 -0500 Rating Details
2023-04-24 16:26:01 -0500 Rating Details
2023-04-24 14:12:49 -0500 Rating Details
2023-04-24 16:14:02 -0500 Rating Details
2023-04-24 14:23:16 -0500 Rating Details
2023-04-24 15:05:56 -0500 Rating Details
2023-04-24 16:50:16 -0500 Rating Details
2023-04-24 14:00:23 -0500 Rating Details
2023-04-24 13:47:25 -0500 Rating Details
2023-04-24 16:00:53 -0500 Rating Details
2023-04-24 13:34:47 -0500 Rating Details
2023-04-24 15:42:48 -0500 Rating Details
2023-04-24 14:15:24 -0500 Rating Details
2023-04-24 13:48:58 -0500 Rating Details
2023-04-24 15:54:16 -0500 Rating Details
2023-04-24 16:08:20 -0500 Rating Details
2023-04-24 16:04:09 -0500 Rating Details
2023-04-24 15:45:32 -0500 Rating Details
2023-04-24 14:10:10 -0500 Rating Details
2023-04-24 14:07:10 -0500 Rating Details
2023-04-24 16:24:59 -0500 Rating Details
2023-04-24 15:59:29 -0500 Rating Details
2023-04-24 14:20:45 -0500 Rating Details
2023-04-24 15:01:26 -0500 Rating Details
2023-04-24 13:42:05 -0500 Rating Details
2023-04-24 15:41:09 -0500 Rating Details
2023-04-24 15:35:33 -0500 Rating Details
2023-04-24 13:49:07 -0500 Rating Details